NANOVIRICIDES, INC. Common Stock (par value $0.00001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 5th, 2024 • Nanoviricides, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 5th, 2024 Company Industry JurisdictionNanoViricides, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with EF Hutton LLC (the “Agent”) as follows: